Pfizer elevates Bourla as Read steps down

Pfizer’s chief executive officer Ian Read is to step down after eight years at the helm of the US pharma giant and take on the role of executive chairman. On 1 January 2019, he will be succeeded by chief operating officer Albert Bourla, who won the “unanimous support” of Pfizer’s board.

More from Leadership

More from HBW Insight